Extracellular vesicle proteomics identifies novel blood biomarkers for the early diagnosis of status epilepticus
This study identifies new plasma biomarkers that may support the early diagnosis of SE, particularly in emergency settings where access to electroencephalography is limited. These findings suggest potential applicability to clinical practice; nevertheless, prospective validation in independent and larger cohorts is required.
Authors
- Laura Abraira (ORCID: https://orcid.org/0000-0002-5119-7929)
- Elena Fonseca (ORCID: https://orcid.org/0000-0002-3895-1237)
- Manuel Quintana (ORCID: https://orcid.org/0000-0003-0288-9088)
- Sofía Lallana (ORCID: https://orcid.org/0000-0002-5999-9889)
- Clara Sanz-Gea (ORCID: https://orcid.org/0000-0003-3574-5718)
- Samuel López‐Maza (ORCID: https://orcid.org/0000-0003-3660-2604)
- Anna Rosell (ORCID: https://orcid.org/0000-0003-1082-3599)
- Manuel Toledo (ORCID: https://orcid.org/0000-0003-1550-3316)
- E. Santamarina (ORCID: https://orcid.org/0009-0006-3940-8953)
- Daniel Campos (ORCID: https://orcid.org/0000-0003-4795-5309)
- Anna Peñalba (ORCID: https://orcid.org/0000-0002-0241-2602)
- Júlia Valor‐Blanque (ORCID: https://orcid.org/0009-0006-2918-7106)
Institutions
- Universitat Autònoma de Barcelona (ES)
- Vall d'Hebron Institut de Recerca (ES)
- Vall d'Hebron Hospital Universitari (ES)
Publication Details
- Journal
- Epilepsia
- Published
- 2025-11-09
- DOI
- https://doi.org/10.1111/epi.70008
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00